礼进生物/LYVGEN
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
礼进生物宣布与百时美施贵宝进行II期临床合作,评估LVGN7409联合纳武利尤单抗注射液治疗非小细胞肺癌 2022-11-28 07:00
1